Analysing a case study
JJ is a 7-year-old male that has been dealing with asthma his entire life. Multiple treatments have been tried, which have helped symptoms, but nothing that works completely. You are treating him and know of a study regarding a new asthma medication being developed. This new medication contains a bronchodilator/steroid/antihistamine as an inhalation. None of the drugs being studied have previously been approved for children under the age of 12. The study would last for 16 weeks.
Explain the ethical and legal implications of the scenario you selected on all stakeholders involved, such as the prescriber, pharmacist, patient, and patient’s family.
Describe strategies to address disclosure and nondisclosure as identified in the scenario you selected. Be sure to reference laws specific to your state.
Explain two strategies that you, as an advanced practice nurse, would use to guide your decision making in this scenario, including whether you would disclose your error. Be sure to justify your explanation.
Explain the process of writing prescriptions, including strategies to minimize medication errors.
Sample Answer
Ethical and Legal Implications
The scenario you selected raises a number of ethical and legal implications for all stakeholders involved.
Prescriber: The prescriber (advanced practice nurse) has a duty to act in the best interests of the patient. This includes balancing the potential benefits of the new medication against the potential risks. The prescriber must also obtain informed consent from the patient or the patient’s parents before enrolling the patient in the study.
Pharmacist: The pharmacist has a duty to dispense medications safely and accurately. This includes ensuring that the patient is aware of all potential risks and benefits of the new medication. The pharmacist must also report any adverse events to the prescriber and the study sponsor.
Patient: The patient (and the patient’s parents) have a right to make informed decisions about their healthcare. This includes the right to know about the potential risks and benefits of the new medication, as well as the right to refuse to participate in the study.